This is just the beginning! Our collection holds over 300 years of history, including rare newspapers, obituaries, marriage records, birth records, and so much more—most of which you won’t find anywhere else!
New umbrella study speeds lung cancer drug testing
A nationwide Lung-MAP trial screens over 200 cancer genes in advanced squamous cell lung cancer patients and assigns them to five drug groups. Five major pharma firms plus the FDA and NCI back the umbrella trial, aiming to match patients with effective therapies quickly and expand access across about 500 hospitals.
MENTIONED IN THIS ARTICLE
U.S
Federal Food and Drug Administration
Ellen Sigal
Friends of Cancer Research
Roy Herbst
Yale Cancer Center
Richard Pardur
FDA
Amgen
Genentech
Pfizer
AstraZeneca PLC
AstraZeneca
National Cancer Institute
Herbst
Breyan Harris
Sacramento
Harris